| Reference |
|
5042
Haruta Y, Seon BK.
Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.
Proc Natl Acad Sci U S A
1986
83(20):7898-902
PubMed ID: 3464004
DOI: 10.1073/pnas.83.20.7898
|
|
2417
Nilsson K, Giovanella, B C, Stehlin, J S, Klein G
Tumorigenicity of human hematopoietic cell lines in athymic nude mice.
Int J Cancer
1977
19:337-44
PubMed ID: 14896
DOI: 10.1002/ijc.2910190309
|
|
1141
Ralph P, Moore, M A, Nilsson K
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.
J Exp Med
1976
143:1528-33
PubMed ID: 1083890
DOI: 10.1084/jem.143.6.1528
|
|
4975
Neumann H, Klein E, Hauck-Granoth R, Yachnin S, Ben-Bassat H.
Comparative study of alkaline phosphatase activity in lymphocytes, mitogen-induced blasts, lymphoblastoid cell lines, acute myeloid leukemia, and chronic lymphatic leukemia cells.
Proc Natl Acad Sci U S A
1976
73(5):1432-6
PubMed ID: 1064015
DOI: 10.1073/pnas.73.5.1432
|
|
971
Klein E, Klein G, Nadkarni, J S, Nadkarni, J J, Wigzell H, Clifford P
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
Cancer Res
1968
28:1300-10
PubMed ID: 4174339
|
|
2416
Klein E, Klein G, Nadkarni, J S, Nadkarni, J J, Wigzell H, Clifford P
Surgace IgM specificity on cells derived from a Burkitt's lymphoma.
Lancet
1967
2:1068-70
PubMed ID: 4168541
DOI: 10.1016/s0140-6736(67)90340-6
|
| User's Publication |
|
22896
Hou J, Uejima T, Tanaka M, Son YL, Hanada K, Kukimoto-Niino M, Yamaguchi S, Hashimoto S, Yokoyama S, Takemori T, Saito T, Shirouzu M, Kondo T.
EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells
Neuro Oncol
2025
27(3):682-694
PubMed ID: 39470407
DOI: 10.1093/neuonc/noae226
|
|
16945
Yano H, Fujiwara Y, Horlad H, Pan C, Kai K, Niino D, Ohsawa K, Higashi M, Nosaka K, Okuno Y, Tamaru JI, Mukasa A, Matsuoka M, Komohara Y.
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy
Cancer Sci
2022
113(6):2129-2143
PubMed ID: 35343027
DOI: 10.1111/cas.15349
|
|
13229
Kakimi K, Matsushita H, Masuzawa K, Karasaki T, Kobayashi Y, Nagaoka K, Hosoi A, Ikemura S, Kitano K, Kawada I, Manabe T, Takehara T, Ebisudani T, Nagayama K, Nakamura Y, Suzuki R, Yasuda H, Sato M, Soejima K, Nakajima J.
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study.
J Immunother Cancer
2020
PubMed ID: 32948652
DOI: 10.1136/jitc-2020-001185
|
|
5030
Tsukamoto M, Imai K, Ishimoto T, Komohara Y, Yamashita YI, Nakagawa S, Umezaki N, Yamao T, Kitano Y, Miyata T, Arima K, Okabe H, Baba Y, Chikamoto A, Ishiko T, Hirota M, Baba H.
PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis.
Cancer Sci
2019
110(1):310-320
PubMed ID: 30426611
DOI: 10.1111/cas.13874
|
|
10069
Motoshima T, Komohara Y, Ma C, Dewi AK, Noguchi H, Yamada S, Nakayama T, Kitada S, Kawano Y, Takahashi W, Sugimoto M, Takeya M, Fujimoto N, Oda Y, Eto M.
PD-L1 expression in papillary renal cell carcinoma.
BMC Urol
2017
17:8
PubMed ID: 28086852
DOI: 10.1186/s12894-016-0195-x
|
|
10269
Komohara Y, Ma C, Yano H, Pan C, Horlad H, Saito Y, Ohnishi K, Fujiwara Y, Okuno Y, Nosaka K, Shimosaki S, Morishita K, Matsuoka M, Wakayama T, Takeya M.
Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages
J Clin Exp Hematop
2017
57:15-20
PubMed ID: 28420814
DOI: 10.3960/jslrt.17003
|
|
13994
Horlad H, Ma C, Yano H, Pan C, Ohnishi K, Fujiwara Y, Endo S, Kikukawa Y, Okuno Y, Matsuoka M, Takeya M, Komohara Y.
An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
Cancer Sci
2016
107(11):1696-1704
PubMed ID: 27564404
DOI: 10.1111/cas.13065
|
|
14309
Ninomiya S, Kawano M, Abe T, Ishikawa T, Takahashi M, Tamura M, Takahashi Y, Nashimoto M.
Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines
PLoS One
2015
10(3):e0118631
PubMed ID: 25730316
DOI: 10.1371/journal.pone.0118631
|
|
13727
Goto H, Matsuda K, Srikoon P, Kariya R, Hattori S, Taura M, Katano H, Okada S.
Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma
Cancer Lett
2013
331(2):174-82
PubMed ID: 23321500
DOI: 10.1016/j.canlet.2012.12.021
|
|
15339
Bai B, Horlad H, Saito Y, Ohnishi K, Fujiwara Y, Takeya M, Komohara Y.
Role of Stat3 activation in cell-cell interaction between B-cell lymphoma and macrophages: the in vitro study
J Clin Exp Hematop
2013
53(2):127-33
PubMed ID: 23995109
DOI: 10.3960/jslrt.53.127
|
|
16574
Izumi T, Kondo M, Takahashi T, Fujieda N, Kondo A, Tamura N, Murakawa T, Nakajima J, Matsushita H, Kakimi K.
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Cytotherapy
2013
15(4):481-91
PubMed ID: 23391461
DOI: 10.1016/j.jcyt.2012.12.004
|
|
2320
Kim C, Matsumura M, Saijo K, Ohno T.
In vitro induction of HLA-A2402-restricted and carcinoembryonic-antigen-specific cytotoxic T lymphocytes on fixed autologous peripheral blood cells.
Cancer Immunol Immunother.
1998
47(2):90-6
PubMed ID: 9769117
DOI: 10.1007/s002620050508
|
|
2318
Liu SQ, Kawai K, Shiraiwa H, Hayashi H, Akaza H, Hashizaki K, Shiba R, Saijo K, Ohno T.
High rate of induction of human autologous cytotoxic T lymphocytes against renal carcinoma cells cultured with an interleukin cocktail.
Jpn J Cancer Res
1998
89(11):1195-201
PubMed ID: 9914789
DOI: 10.1111/j.1349-7006.1998.tb00515.x
|
|
1415
Okubo M, Brown MP, Chiba K, Kasukawa R, Nishimaki T.
Detection of TNF alpha and Fas ligand mRNA within synovial mononuclear cells by fluorescence in-cell labeling PCR (FICL-PCR)
Mol Biol Rep
1998
25(4):217-24
PubMed ID: 9870611
DOI: 10.1023/a:1006863303503
|
Back
Top
CELL BANK Website